表紙
市場調査レポート

米国の出生前検査市場

Prenatal Testing Market in the US 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 295857
出版日 ページ情報 英文 54 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
米国の出生前検査市場 Prenatal Testing Market in the US 2014-2018
出版日: 2014年01月24日 ページ情報: 英文 54 Pages
概要

米国の出生前検査市場は、2013年から2018年にかけて、5.34%のCAGRで拡大する見通しです。しかし、出産率の減少が、この成長を阻害する要因となる可能性があります。

当レポートでは、米国における出生前検査市場の現状と将来予測、技術別の市場動向、市場の成長因子と課題、主要ベンダーの情報などを提供しており、概略以下の構成でお届けします。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 技術別の市場区分

  • 技術別の出生前検査市場
    • 侵襲出生前検査
    • 非侵襲出生前検査

第8章 購入基準

第9章 市場成長因子

第10章 成長因子とその影響

第11章 市場の課題

第12章 成長因子と課題の影響

第13章 市場動向

第14章 動向とその影響

第15章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M&A
  • 市場シェア分析
  • その他の有力ベンダー

第16章 主要ベンダーの分析

  • PerkinElmer Inc.
  • Quest Diagnostics Inc.
  • Sequenom Inc.
  • Verinata Health Inc.

第17章 関連レポート

目次
Product Code: IRTNTR3260

TechNavio's analysts forecast the Prenatal Testing market in the US to grow at a CAGR of 5.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of fetal health-related abnormalities. The Prenatal Testing market in the US has also been witnessing the significant increase in the launch of new tests. However, the falling fertility rates in the US could pose a challenge to the growth of this market.

TechNavio's report, the Prenatal Testing Market in the US 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on the US; it also covers the Prenatal Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space are PerkinElmer Inc., Quest Diagnostics Inc., Sequenom Inc., and Verinata Health Inc.

Other vendors mentioned in the report are ANGLE plc, Ariosa Diagnostics Inc., BGI Health, CellScape Corp., Fluidigm Corp., Ikonisys Inc., Kellbenx Inc., Natera Inc., Ravgen Inc., and Trovagene Inc.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Technology

  • 07.1. Prenatal Testing Market in the US by Technology
    • 07.1.1. Invasive Prenatal Testing
    • 07.1.2. Non-invasive Prenatal Testing

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape

  • 15.1. Competitive Scenario
    • 15.1.1. Key News
    • 15.1.2. Mergers and Acquisitions
  • 15.2. Market Share Analysis 2013
  • 15.3. Other Prominent Vendors

16. Key Vendor Analysis

  • 16.1. PerkinElmer Inc.
    • 16.1.1. Business Overview
    • 16.1.2. Business Segmentation
    • 16.1.3. Key Information
    • 16.1.4. SWOT Analysis
  • 16.2. Quest Diagnostics Inc.
    • 16.2.1. Business Overview
    • 16.2.2. Business Segmentation
    • 16.2.3. Key Information
    • 16.2.4. SWOT Analysis
  • 16.3. Sequenom Inc.
    • 16.3.1. Business Overview
    • 16.3.2. Business Segmentation
    • 16.3.3. Key Information
    • 16.3.4. SWOT Analysis
  • 16.4. Verinata Health Inc.
    • 16.4.1. Business Overview
    • 16.4.2. Key Information
    • 16.4.3. SWOT Analysis

17. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Prenatal Testing Market in the US Overview
  • Exhibit 3: Prenatal Testing Market in the US 2013-2018 (US$ billion)
  • Exhibit 4: Prenatal Testing Market in the US Segmentation by Technology
  • Exhibit 5: Prenatal Testing Market in the US Segmentation 2013
  • Exhibit 6: Global Incidence of Chromosomal Abnormalities in Newborns
  • Exhibit 7: Business Segmentation of PerkinElmer Inc.
  • Exhibit 8: Business Segmentation of Quest Diagnostics Inc.
  • Exhibit 9: Business Segmentation of Sequenom Inc.
Back to Top